UPLC methodology for identification and quantitation of naturally fluorescent crosslinks in proteins: a study of bone collagen.
Methods used to determine collagen crosslinks in different connective tissues require a relatively large amount of material and include a number of experimental steps. We addressed these issues by developing the first ultrahigh-pressure liquid chromatography (UPLC) methodology for detection and quantification of naturally fluorescent enzymatic (pyridinoline, deoxypyridinoline) and senescent (pentosidine) crosslinks using nanogram amounts of acid-hydrolyzed bone and purified bone collagen. Not only the developed set of UPLC methods relies on a single column analysis of all three fluorescent crosslinks in one separation step, but under different separation conditions, the same column is also used to determine hydroxyproline concentration necessary to calculate collagen contents in the samples making this a unique feature of our methodology. The determined detection limit was 10 fmol for the pyridinium crosslinks and 1.5 fmol for pentosidine. The smallest pieces of human cortical bones were 224-240 ng in weight and this is approx. 10(6)-fold less as compared to some high-pressure LC (HPLC) methods that need a minimum of approx. 0.50-1 mg of a bone sample. In general, our UPLC methodology can be applied to analysis of similar crosslinks in various collagenous tissues as well as purified/recombinant proteins of different origin. Thus, in addition to biomedical and bone research, this work is of general importance to other fields including biology, forensic, anthropology and archaeology, where samples could truly be rare, minute and precious.
Center for Biotechnology and Interdisciplinary Studies, Department of Biomedical Engineering, Rensselaer Polytechnic Institute, Troy, NY 12180-3590, USA.
Grażyna E
GE
Sroga
Deepak
D
Vashishth
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000596:Amino Acids / Q000737:chemistry; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D003094:Collagen / Q000032:analysis / Q000737:chemistry*; D006801:Humans; D006909:Hydroxyproline / Q000032:analysis / Q000737:chemistry*; D016014:Linear Models; D008875:Middle Aged; D008956:Models, Chemical; D015203:Reproducibility of Results; D013050:Spectrometry, Fluorescence; D013977:Tibia / Q000737:chemistry
D000596:Amino Acids; C015484:pyridinoline; C036020:deoxypyridinoline; D003094:Collagen; D006909:Hydroxyproline
Bone. 2001 Feb;28(2):195-201
11182378
J Bone Miner Res. 2007 Mar;22(3):425-33
17181395
Crit Rev Eukaryot Gene Expr. 2005;15(4):343-58
16472064
Proc Natl Acad Sci U S A. 2005 Mar 22;102(12):4409-13
15753298
Osteoporos Int. 2008 Mar;19(3):329-37
18094911
Anal Biochem. 1986 May 1;154(2):431-5
3728962
Proc Natl Acad Sci U S A. 1976 May;73(5):1447-51
1064018
J Bone Miner Metab. 2008;26(1):93-100
18095070
Methods Enzymol. 1982;82 Pt A:372-98
7078444
Anal Biochem. 1988 Feb 15;169(1):197-203
3369682
Osteoporos Int. 2006;17(3):319-36
16341622
Osteoporos Int. 2010 Feb;21(2):195-214
19760059
Bone. 2007 May;40(5):1259-64
17329178
J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Jan 1;877(1-2):1-7
19027371
Anal Biochem. 1997 Nov 1;253(1):26-32
9356137
Osteoporos Int. 2009 Jun;20(6):887-94
18850239
Bone. 2006 Nov;39(5):1073-1079
16829221
J Chromatogr B Biomed Sci Appl. 1997 Dec 5;703(1-2):37-44
9448060